Osaka Research Institute of Industrial Science and Technology, Osaka, Japan
Department of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
Appl Environ Microbiol. 2020 Jul 2;86(14). doi: 10.1128/AEM.00525-20.
Many phenylalanine- and tyrosine-producing strains have used plasmid-based overexpression of pathway genes. The resulting strains achieved high titers and yields of phenylalanine and tyrosine. Chromosomally engineered, plasmid-free producers have shown lower titers and yields than plasmid-based strains, but the former are advantageous in terms of cultivation cost and public health/environmental risk. Therefore, we engineered here the chromosome to create superior phenylalanine- and tyrosine-overproducing strains that did not depend on plasmid-based expression. Integration into the chromosome of two central metabolic pathway genes ( and ) and eight shikimate pathway genes (, , , , , , , and ), controlled by the T7lac promoter, resulted in excellent titers and yields of phenylalanine; the superscript "" indicates that the enzyme encoded by the gene was feedback resistant. The generated strain could be changed to be a superior tyrosine-producing strain by replacing with A rational approach revealed that integration of seven genes (, , , , , , and ) was necessary as the minimum gene set for high-yield phenylalanine production in MG1655 (, , , , , and deletant). The phenylalanine- and tyrosine-producing strains were further applied to generate phenyllactic acid-, 4-hydroxyphenyllactic acid-, tyramine-, and tyrosol-producing strains; yield of these aromatic compounds increased proportionally to the increase in phenylalanine and tyrosine yields. Plasmid-free strains for aromatic compound production are desired in the aspect of industrial application. However, the yields of phenylalanine and tyrosine have been considerably lower in plasmid-free strains than in plasmid-based strains. The significance of this research is that we succeeded in generating superior plasmid-free phenylalanine- and tyrosine-producing strains by engineering the chromosome, which was comparable to that in plasmid-based strains. The generated strains have a potential to generate superior strains for the production of aromatic compounds. Actually, we demonstrated that four kinds of aromatic compounds could be produced from glucose with high yields (e.g., 0.28 g tyrosol/g glucose).
许多苯丙氨酸和酪氨酸产生菌已利用质粒过表达途径基因。由此产生的菌株实现了苯丙氨酸和酪氨酸的高滴度和产率。与基于质粒的菌株相比,染色体工程化、无质粒的生产菌的滴度和产率较低,但前者在培养成本和公共卫生/环境风险方面具有优势。因此,我们在这里对染色体进行了工程改造,以创建不依赖于基于质粒表达的高产苯丙氨酸和酪氨酸的生产菌。将两个中心代谢途径基因(和)和八个莽草酸途径基因(、、、、、、和)整合到染色体中,这些基因受 T7lac 启动子控制,导致苯丙氨酸的滴度和产率非常高;上标“”表示基因编码的酶对反馈抑制具有抗性。通过用 替换 ,该生成的菌株可以转变为高产酪氨酸的菌株。通过整合七个基因(、、、、、和),可以在 MG1655(,,,,,和 缺失突变体)中作为最小的基因集用于高产苯丙氨酸生产,这是一种合理的方法。苯丙氨酸和酪氨酸产生菌进一步用于生成苯乳酸、4-羟基苯乳酸、酪胺和对羟基苯乙醇产生菌;这些芳香族化合物的产量与苯丙氨酸和酪氨酸产量的增加成正比。从工业应用的角度来看,需要使用无质粒的芳香族化合物生产菌。然而,无质粒菌株的苯丙氨酸和酪氨酸产量明显低于基于质粒的菌株。本研究的意义在于,我们通过工程改造染色体成功地生成了优于基于质粒的菌株的无质粒高产苯丙氨酸和酪氨酸生产菌。所生成的菌株具有生成用于生产芳香族化合物的优良菌株的潜力。实际上,我们证明了可以从葡萄糖中以高产量(例如,0.28 g 对羟基苯乙醇/g 葡萄糖)生产四种芳香族化合物。